Announced Sat, 11 Jul · 16:54 IST
Routine RTA compliance certificate filed with BSE and NSE
Compliance View source PDF
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.9%1-day move
₹1008.45
prior close
₹1009.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.8-0.0+0.0+4.9+9.2+6.8+2.9+3.8-0.8————
Up moveDown movePending
AI summary
Orchid Pharma submitted the quarterly confirmation certificate under SEBI Regulation 74(5) for Q1 FY26-27, ended June 30, 2026. The certificate was issued by Abhipra Capital, the company's Registrar and Share Transfer Agent, confirming compliance with depository regulations. This is a standard procedural filing with no business or financial substance.
Likely market impact
No material impact for shareholders. This is a routine quarterly compliance filing required of all listed companies.